| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.26 | 2e-09 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.25 | 9e-09 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.34 | 5e-08 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.33 | 9e-08 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.23 | 2e-07 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-07 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.22 | 3e-07 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-06 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.21 | 7e-06 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.31 | 1e-05 |